Skip to content

Clinical trials

Immunoblastic Lymphadenopathy trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Country / region: Japan Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb1
SymBio Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy2
Leukemia-Lymphoma, Adult T-Cell2
Lymphoma2
Lymphoma, Large-Cell, Anaplastic2
Lymphoma, T-Cell2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Recurrence2
Epstein-Barr Virus Infections1
Lymphoma, Extranodal NK-T-Cell1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 26 to 2 of 2. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.